Ken Cunningham is listed as a director on 2 SEC Form D filings by 1 issuer between Jul 2016 and Jul 2020: Verona Pharma plc (London, United Kingdom (as filed: X0) — pharmaceuticals — 2016–2020; $200.2M reported sold to 43 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Anders Ullman (2 shared filings), David Ebsworth (2 shared filings), Andrew Sinclair (1 shared filing), Claire Poll (1 shared filing), David Zaccardelli (1 shared filing) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ken. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Ken Cunningham and found 4 differences: Form D filed 33 days after the first sale; Same name, different state: "Ken Cunningham" (IL) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.